CLOV icon

Clover Health Investments

3.58 USD
-0.01
0.28%
At close Apr 1, 3:59 PM EDT
After hours
3.59
+0.01
0.28%
1 day
-0.28%
5 days
-7.49%
1 month
-1.65%
3 months
14.38%
6 months
28.78%
Year to date
14.38%
1 year
365.12%
5 years
-64.90%
10 years
-64.90%
 

About: Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Employees: 570

0
Funds holding %
of 7,398 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

122% more call options, than puts

Call options by funds: $27M | Put options by funds: $12.2M

100% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 20

88% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 33

26% more capital invested

Capital invested by funds: $232M [Q3] → $293M (+$61.2M) [Q4]

13% more funds holding

Funds holding: 157 [Q3] → 177 (+20) [Q4]

2.41% more ownership

Funds ownership: 20.16% [Q3] → 22.57% (+2.41%) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$4.50
26%
upside
Avg. target
$4.50
26%
upside
High target
$4.50
26%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Canaccord Genuity
Richard Close
41% 1-year accuracy
11 / 27 met price target
26%upside
$4.50
Buy
Maintained
3 Mar 2025

Financial journalist opinion

Based on 3 articles about CLOV published over the past 30 days

Negative
Seeking Alpha
3 weeks ago
Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth
Clover Health Investments' AI capabilities are a major driver for its topline and bottom-line improvements in FY 2024. Clover Health's MCR in Q4 represented a decline from Q3, unlike past years, and rivaled its Q2 MCR, a sign of the impact of its AI capabilities. While Clover expects its margins to contract in FY 2025, its increased investments this year set it up for a highly profitable future starting from FY 2026, in my opinion.
Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth
Positive
MarketBeat
3 weeks ago
Missed the Hims & Hers Rally? Clover Health Could Be Next
Shares of Hims & Hers Health Inc. NYSE: HIMS have made a splash in recent weeks, reaching a new all-time high of just under $73 per share. However, a few days later, most of the upside moved right back, crashing down to as low as $36 per share.
Missed the Hims & Hers Rally? Clover Health Could Be Next
Neutral
GlobeNewsWire
4 weeks ago
Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians
New functionality within Counterpart Assistant uses Google Cloud's Vertex AI Search to give clinicians comprehensive insights across multiple sources of patient health data New functionality within Counterpart Assistant uses Google Cloud's Vertex AI Search to give clinicians comprehensive insights across multiple sources of patient health data
Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians
Positive
Zacks Investment Research
1 month ago
CLOV Q4 Earnings Beat Estimates, Sales Miss, Membership Rises
Clover Health's fourth-quarter 2024 results continue to benefit from the strength of its strong member retention. Strong revenue outlook bodes well.
CLOV Q4 Earnings Beat Estimates, Sales Miss, Membership Rises
Neutral
Seeking Alpha
1 month ago
Clover Health Investments, Corp. (CLOV) Q4 2024 Earnings Call Transcript
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer Peter Kuipers - Chief Financial Officer Conference Call Participants Jonathan Yong - UBS Tolf Cormanon - Craig Hallam Operator Ladies and gentlemen, good afternoon and welcome to the Clover Health Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Clover Health Investments, Corp. (CLOV) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Clover Health Investments, Corp. (CLOV) Tops Q4 Earnings Estimates
Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.12 per share a year ago.
Clover Health Investments, Corp. (CLOV) Tops Q4 Earnings Estimates
Neutral
GlobeNewsWire
1 month ago
Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance
Full year 2024 GAAP Net loss from continuing operations improves by $164 million year-over-year Full year 2024 Adjusted EBITDA of $70 million, representing an increase of $112 million year-over-year Company well positioned to invest in membership growth and Clover Assistant technology, while maintaining strong profitability Issues full year 2025 guidance: Average Medicare Advantage membership of 103,000 - 107,000, representing 30% growth year-over-year at the midpoint Insurance revenue between $1.800 billion and $1.875 billion, representing 37% growth year-over-year at the midpoint Adjusted EBITDA profitability between $45 million and $70 million Adjusted Net income between $45 million and $70 million WILMINGTON, Del., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today reported financial results for the fourth quarter and full year 2024.
Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance
Neutral
GlobeNewsWire
1 month ago
Clover Health to Participate in Upcoming Investor Conferences
WILMINGTON, Del., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced its participation in the following investor conferences: CFO, Peter Kuipers, will participate in the 2025 Jefferies Value-Based Healthcare Summit on Monday, March 10, 2025.
Clover Health to Participate in Upcoming Investor Conferences
Neutral
GlobeNewsWire
1 month ago
Clover Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report fourth quarter and full year 2024 financial results after market close on Thursday, February 27, 2025.
Clover Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Negative
Seeking Alpha
1 month ago
Clover Health: Watch Out For Volatility Following Q4 Earnings Results
I remain bullish on Clover Health long-term but prefer to Hold until Q4 2024 earnings for higher conviction before initiating a long position in this stock. I believe the 40% YTD rise and 60% retail ownership increase the risk of profit taking post-earnings, similar to the Q3 panic selloff. On the positive side, the company has recently reported a 27% increase in Medicare Advantage members, surpassing 100,000 lives, with 95% in its 4-Star PPO plan.
Clover Health: Watch Out For Volatility Following Q4 Earnings Results
Charts implemented using Lightweight Charts™